Tumour

A tumour, or neoplasm, is an abnormal mass of tissue that forms when cells grow and divide more than they should or do not die when they should. This uncontrolled cellular proliferation results from genetic and epigenetic alterations that disrupt the normal regulatory mechanisms governing cell division, differentiation, and apoptosis. Tumours are broadly classified into two main categories: benign and malignant.

Benign tumours are generally localized, encapsulated, and do not invade surrounding tissues or metastasize. Their cells, while abnormal, retain a degree of differentiation. Examples include fibromas and adenomas.

Malignant tumours, conversely, are characterized by uncontrolled invasion of adjacent tissues and the capacity to spread to distant sites through the bloodstream or lymphatic system, a process known as metastasis. These are the tumours we commonly refer to as cancer. Further classification involves histopathological examination to determine the cell type of origin (e.g., carcinoma from epithelial cells, sarcoma from connective tissue, leukemia from blood-forming cells) and their grade, indicating how abnormal the cells appear under a microscope.

The recognition of tumours dates back to antiquity. The Edwin Smith Papyrus, an ancient Egyptian medical text from around 1600 BCE, describes eight cases of tumours, some of which were surgically removed, indicating a rudimentary understanding of their physical presence and potential for intervention. Hippocrates, the 'father of medicine' in ancient Greece (c. 460–370 BCE), is credited with coining the term 'carcinos' (crab-like) to describe malignant tumours due to their appearance and invasive nature.

He believed humors (bodily fluids) were imbalanced, leading to disease. Galen, a Roman physician (129–210 CE), further elaborated on tumour types and proposed treatments. For centuries, understanding was limited by the inability to see microscopic structures. The invention of the microscope in the 17th century revolutionized pathology, allowing scientists like Rudolf Virchow in the 19th century to establish the cellular basis of disease, proposing that all cells arise from pre-existing cells and that tumours are derived from abnormal cells.

This laid the groundwork for modern oncology.

The significance of tumours, particularly malignant ones, cannot be overstated. Cancer remains a leading global cause of mortality, imposing immense burdens on individuals, families, healthcare systems, and economies. The complexity of tumour biology presents a formidable challenge to medical science.

Understanding tumourigenesis-the process by which normal cells transform into cancerous ones-is crucial for developing effective diagnostic, prognostic, and therapeutic strategies. Research into tumours has been a powerful engine for scientific discovery, driving advancements in molecular biology, genetics, immunology, and pharmacology. The development of targeted therapies, immunotherapies, and sophisticated imaging techniques are direct outcomes of intensive study into tumour behaviour.

Furthermore, the study of tumours has illuminated fundamental biological processes, such as cell cycle regulation, DNA repair, and signal transduction pathways, with implications far beyond cancer.

Tumourigenesis is a multi-step process driven by the accumulation of genetic and epigenetic changes that confer upon cells a set of 'hallmarks of cancer.' These include sustained proliferative signaling, evading growth suppressors, resisting cell death (apoptosis), enabling replicative immortality, inducing angiogenesis (the formation of new blood vessels to feed the tumour), and activating invasion and metastasis. Oncogenes, mutated proto-oncogenes, promote cell growth, while mutations in tumour suppressor genes, like p53, remove critical brakes on cell division and survival.

Epigenetic modifications-changes in gene expression without altering the DNA sequence-also play a vital role, silencing tumour suppressor genes or activating oncogenes. The tumour microenvironment, comprising surrounding stromal cells, immune cells, and extracellular matrix, also significantly influences tumour growth, progression, and response to therapy, adding another layer of complexity to understanding and treating these diseases.